Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - salbutamol sulfate 29.64mg equivalent to salbutamol 100 µg/actuation (200 doses);   - aerosol inhaler, metered dose - 100 mcg/dose - active: salbutamol sulfate 29.64mg equivalent to salbutamol 100 µg/actuation (200 doses)   excipient: ethanol norflurane - salbutamol provides short-acting (4 hour) bronchodilation with fast onset (within 5 minutes) in reversible airways obstruction due to asthma, chronic bronchitis and emphysema. it is suitable for long-term use in the relief and prevention of asthmatic symptoms. salamol cfc-free inhaler should be used to relieve symptoms when they occur and to prevent them in those circumstances recognised by the patient to precipitate an asthmatic attack (e.g. before exercise or unavoidable allergen exposure).

Ísrael - enska - Ministry of Health

glaxo smith kline (israel) ltd - salbutamol as sulfate - inhaler - salbutamol as sulfate 100 mcg/dose - salbutamol - salbutamol - ventolin inhaler cfc free is a short-acting (4 to 6 hour) bronchodilator with fast (within 5 minutes) onset in reversible airways obstruction. it is particularly suitable for the relief and prevention of asthma symptoms it should be used to relieve symptoms when they occur, and to prevent them in those circumstances recognized by the patient to precipitate an asthma attack (e.g. before exercise or unavoidable allergen exposure).ventolin inhaler cfc free is particularly valuable as relief medication in mild, moderate or severe asthma, provided that reliance on it does not delay the introduction and use of regular inhaled corticosteroid therapy.

Egyptaland - enska - EDA (Egyptian Drug Authority)

mostafa ghannam - freeze-dried serum gonadotrophin (pmsg) - freeze dried tablet

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 33175 - metallic femoral head prosthesis - freedom constrained modular head component hip joint replacement prosthesis. made from co-cr-mo alloy. type 12/14 taper. 15 degree circumferential flat to provide additional dislocation resistance. the freedom constrained modular head is intended for use as a femoral component of a total hip prosthesis with the freedom constrained liner system. for primary and revision patients at high risk of dislocation due to a previous history of dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease or intra-operative instability, and for whom all other options to constrained acetabular components have been considered.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - fluticasone propionate, quantity: 250 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - for use in the prophylactic management of asthma in adults and children over 4 years of age.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - fluticasone propionate, quantity: 125 microgram/actuation - inhalation, pressurised - excipient ingredients: norflurane - for use in the prophylactic management of asthma in adults and children over 4 years of age.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 4000 pfu/ml; isoleucine, quantity: 0.355 mg; leucine, quantity: 0.432 mg - injection, powder for - excipient ingredients: lactose; sorbitol; mannitol; threonine; serine; proline; glycine; alanine; valine; methionine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - varilrix hsa-free is indicated for active immunisation against varicella of healthy subjects from 9 months of age. groups who would particularly benefit from vaccination include: non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres. non-immune parents of young children. non-immune household contacts, both adults and children, of immunocompromised patients with no history of the disease.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 4000 pfu/ml; isoleucine, quantity: 0.355 mg - injection, powder for - excipient ingredients: lactose; mannitol; sorbitol; threonine; serine; proline; glycine; alanine; valine; methionine; leucine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - varilrix hsa-free is indicated for active immunisation against varicella of healthy subjects from 9 months of age. groups who would particularly benefit from vaccination include: non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres. non-immune parents of young children. non-immune household contacts, both adults and children, of immunocompromised patients with no history of the disease.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - live varicella vaccine, quantity: 4000 pfu/ml - injection, powder for - excipient ingredients: lactose; mannitol; sorbitol; threonine; serine; proline; glycine; alanine; valine; methionine; isoleucine; leucine; tyrosine; phenylalanine; tryptophan; lysine hydrochloride; histidine; arginine - varilrix hsa-free is indicated for active immunisation against varicella of healthy subjects from 9 months of age. groups who would particularly benefit from vaccination include: non-immune adults, especially those in at-risk occupations such as health care workers, teachers and workers in children's day-care centres. non-immune parents of young children. non-immune household contacts, both adults and children, of immuncompromised patients with no history of the disease.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

zimmer biomet pty ltd - 44362 - constrained polyethylene acetabular liner - freedom ringloc constrained liner component hip joint replacement prosthesis. made from uhmwpe with titanium ring. pre-assembled constraining ring for head and liner assembly in situ. maximum range of motion 114 degrees. the freedom ringloc constrained liner is intended for use as an acetabular component of a total hip prosthesis in primary and revision patients at high risk of dislocation due to a previous history of dislocation, bone loss, joint or soft tissue laxity, neuromuscular disease or intra-operative instability, and for whom all other options to constrained acetabular components have been considered.